source
- OMass Therapeutics secures $310M Series C, eyes status as Britain’s leading biotechOMass Therapeutics, an Oxford‑based biotech still in pre‑clinical stage, announced a new financing round that brings in $310 million. The series C, co‑led by Bain Capital Life Sciences, Forbion an…
- GSK to cut up to 1,217 jobs in Belgium as cost-saving plan acceleratesGSK announced it will lay off up to 1,217 employees in Belgium as part of its global cost-saving program. The cuts will affect R&D, manufacturing and support functions across the company's three m…